Xu et al. [27] finally showed that LMTK3 abundance correlates with ITGB1 expression in breast cancers through immunohistochemistry, suggesting that LMTK3 promotes invasiveness through ITGB1 transcription which reduces survival in breast cancer. The gene discussed is LMTK3; the disease is breast carcinoma.